CAPA  >  CAPA Pharmaceutical

CAPA in Pharmaceutical Industry

CAPA in Pharmaceutical industry

CAPA in Pharmaceutical industry

What are the Importance of CAPA in the Pharmaceutical Industry?

CAPA or Corrective Action and Preventive Action is critical in the pharmaceutical industry to enable the analysis, correction, and prevention issues. It is a framework that facilitates identifying potential risks, the root causes of an issue, and implementing solutions to mitigate and prevent their occurrence and recurrence.

For effective management of CAPA in the pharmaceutical industry, the following are key:

Effective Auditing
Effective Audits

Audit findings are one of the important ways an organization can identify potential issues and implement mitigating measures to prevent them from becoming a reality. In pharma manufacturing, it is common for human error and environmental factors to result in cGMP violations. This can lead to penalties, nonconformances, and noncompliance.

Periodic audits can help businesses identify systemic errors that can lead to issues that need preemptive action to mitigate risks and improve quality throughout the product development life cycle.

The audit findings enable triggering CAPA action. A well-developed CAPA Management Software improves the effectiveness of audits and inspections, enabling the proper implementation, documentation, maintenance, and production of audits and inspections.

Increase Overall Efficiency
Overall Efficiency

Efficient CAPA Management results in continuous improvement of the quality management system, lowering overall operational costs and reducing errors and the resulting rework, scrapping, and wastage. This frees up resources to focus on product innovation and improvement.

This lowers the cost of manufacturing, improves the quality of products, and enhances competitive advantage. As a result, brand reputation also improves, accelerating growth.

Saving Cost
Cost Savings

One of the main advantages of CAPA is cost-saving, resulting in efficient output with optimum quality. It enhances the reliability of processes, systems, and products, cost savings, and higher revenues that can be invested for further improvements in a virtuous growth cycle.

Often, businesses hesitate to invest in the CAPA as it may require high investment and skilled personnel. However, the RoI validates the investment over time as it reduces problems and establishes a quality culture. Better process performance and reduced downtime and failures further enhance the growth rate.

Better Product Quality
Better Product Quality

Product performance and safety are the key elements, along with the right pricing and reach, that make a product successful. CAPA enables identifying and correcting errors, which leads to process improvement and enhances product quality. The preventive action part of CAPA also enables businesses to proactively identify potential errors and capture trends of recurring errors to prevent their occurrence. Continuous monitoring of the CAPA systems ensures the effectiveness of the corrective and preventive actions, ensuring the goals are achieved, the product quality is improved, and product failure risks are lowered.

Find out more about CAPA management from ComplianceQuest. Watch the webinar:

  • What are the Requirements of CAPA in Pharmaceutical Industry?

    CAPA is not only good for business, it is also a regulatory requirement for the pharmaceutical industry.

    • CAPA forms one of the 4 key elements of the ICH Q10, a harmonized model for Quality Systems, that pharmaceutical companies can implement to simplify compliance. As it draws from existing models such as cGMP, businesses are not required to create an alternate model of quality requirements.

      For companies following the ICH Q10 pharmaceutical quality system, a CAPA system must be implemented for handling:

      • Complaints
      • Product rejections
      • Nonconformances
      • Recalls
    • FDA cGMP requires pharmaceutical companies to implement well-defined and documented CAPA procedures. The first step in the system is to identify the appropriate sources of product and quality problems. The businesses must use data to spot unfavorable trends while ensuring that the data received by the CAPA system are complete, accurate, and timely. Only appropriate statistical methods must be employed to determine the recurring quality issues.

      When errors are spotted, failure investigation procedures must be initiated, appropriate corrective and preventive actions must be identified, verified, and validated, and the implementation should be effective. The process must be documented and up to date.

      The Information must be shared with the relevant stakeholders and be part of the management review for further deliberation and action.

    • The ISO is not a regulatory body but a standardization body that decides the standards for various processes, including the Quality Management System (QMS). It forms the bulwark on which most regulations are framed. The QMS standards outlined by ISO focus on product quality. The CAPA module is a critical part of the comprehensive QMS.

      ISO 9000:2015 puts the responsibility for taking action and controlling the nonconformities on the pharmaceutical manufacturer. This includes eliminating the true cause of the nonconformity. The manufacturer must enable this by

      • Investigating the nonconformity,
      • Identifying the root causes
      • Verifying if similar nonconformities have been reported or could potentially occur,
      • Implementing corrective and preventive actions
      • Monitoring them for effectiveness
      • Continuously improving it by analyzing risks and opportunities
      • Documenting the process

    Find out how to be compliant. Watch our webinar: Writing CAPAs The Right Way

Document, Training and Change

A Fool-proof Plan for Building an Effective CAPA Process

What are the Best Practices of CAPA in Pharmaceutical Industry?

CAPA implementation includes:

  • Identifying the problem in product or quality based on information from sources such as complaints, audits, returned product records, installation reports, lawsuits, and non-conforming products.

  • The problem must be evaluated to decide whether it needs CAPA. Not all problems need a CAPA solution, as it is a resource-intensive process. Only certain risks must be addressed and their impact evaluated.

  • Once the problem has been evaluated and a decision taken to implement one, the next step is to investigate the problem to identify the root cause and the nature of the solution it needs. It should elucidate the desired objectives after analyzing data.

  • Documenting the root cause will facilitate improving the solution and its implementation.

  • The next step is to develop an action plan. Ideally, a cross-functional team should be involved in the CAPA to design and implement an effective solution.

  • Once the plan is ready, it needs to be implemented. The plan must be shared with the relevant teams, get their buy-in, and train them in case any new skills are needed.

  • Monitoring and tracking is the final step that ensures the implementation is effective and that the CAPA solution delivers the desired results.

mustangbio case study

Watch Webinar

Keep the Heart of QMS Robust: Master How to Ensure Effective Corrective Action in the CAPA Process

mustangbio case study
Watch Webinar

How can a QMS Help with Effective CAPA Management in Pharma?

A cloud-based QMS software provides visibility into processes and access to holistic, real-time data for identifying issues, investigating causes, implementing solutions, documentation, and monitoring and tracking. Transparency enables businesses to quickly assess the efficiency of the CAPA solution and implement corrections if needed. It helps monitor key performance indicators to enable continuous improvement.

Effective CAPA Management in Pharma

A great QMS package

CQ has proven to be intuitive, easy to use and customization is as easy as speaking to the CQ team. The validation scripts are straightforward and easy to edit to meet our organizations particular needs. The system feels familiar while delivering the QMS system tools that we need and the CQ team is responsive to any questions that arise.

Dorothy Wilson,
Quality Assurance & Document and Records Specialist

Origen Biomedical Logo
Origen Biomedical Logo

What are Some Common Challenges with CAPA in the Pharmaceutical Industry?

Some of the common challenges pharma companies face in implementing continuous action preventive action include

Manual processes that hinder the identification of potential risks and problems in product and quality till it is too late.

If the Root Cause Analysis is effective, it can leave the company even more vulnerable as the problem continues to occur or takes new forms.

Inability to track and monitor progress can make the system ineffective and continue to create issues.

CAPA management is resource intensive, and without proper tools, it can delay time to market.

Collaboration and communication can be challenging, as well as version control due to the lack of a unified view.

Find out the Challenges Related to Escalating Complaints to CAPA,

Automating the CAPA will help businesses ensure its effectiveness. To know how ComplianceQuest CAPA software can enable this, read our complete guide:

Quality-centric Companies Rely on CQ QMS

  • affinivax mono
  • verily mono
  • 3m logo mono
  • tupperware mono
  • continental logo mono
  • vyaire mono
  • lifescan mono
  • lundbeck mono
  • cdc logo mono
  • qlik mono
  • csa group mono
  • impossible mono
  • fluence mono

Related Insights

Connect with a CQ Expert

Learn about all features of our Product, Quality, Safety, and Supplier suites. Please fill the form below to access our comprehensive demo video.


Please confirm your details

Request Demo